Ruiz-Llorente L - Search Results

1

Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study.

Ruiz-Llorente L, Ortega-Gutiérrez S, Viso A, Sánchez MG, Sánchez AM, Fernández C, Ramos JA, Hillard C, Lasunción MA, López-Rodríguez ML, Díaz-Laviada I. Ruiz-Llorente L, et al. Br J Pharmacol. 2004 Feb;141(3):457-67. doi: 10.1038/sj.bjp.0705628. Epub 2004 Jan 12. Br J Pharmacol. 2004. PMID: 14718261 Free PMC article.

2

Expression of functionally active cannabinoid receptor CB1 in the human prostate gland.

Ruiz-Llorente L, Sánchez MG, Carmena MJ, Prieto JC, Sánchez-Chapado M, Izquierdo A, Díaz-Laviada I. Ruiz-Llorente L, et al. Prostate. 2003 Feb 1;54(2):95-102. doi: 10.1002/pros.10165. Prostate. 2003. PMID: 12497582

3

Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.

Sánchez MG, Ruiz-Llorente L, Sánchez AM, Díaz-Laviada I. Sánchez MG, et al. Cell Signal. 2003 Sep;15(9):851-9. doi: 10.1016/s0898-6568(03)00036-6. Cell Signal. 2003. PMID: 12834810

4

Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells.

Sánchez MG, Sánchez AM, Ruiz-Llorente L, Díaz-Laviada I. Sánchez MG, et al. FEBS Lett. 2003 Dec 18;555(3):561-6. doi: 10.1016/s0014-5793(03)01349-8. FEBS Lett. 2003. PMID: 14675774 Free article.

5

Signal transduction activated by cannabinoid receptors.

Díaz-Laviada I, Ruiz-Llorente L. Díaz-Laviada I, et al. Mini Rev Med Chem. 2005 Jul;5(7):619-30. doi: 10.2174/1389557054368808. Mini Rev Med Chem. 2005. PMID: 16026308 Review.

6

Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer.

Martínez-Iglesias O, Ruiz-Llorente L, Sánchez-Martínez R, García L, Zambrano A, Aranda A. Martínez-Iglesias O, et al. Clin Transl Oncol. 2008 Jul;10(7):395-8. doi: 10.1007/s12094-008-0221-x. Clin Transl Oncol. 2008. PMID: 18628067 Review.

7

Thyroid receptor: roles in cancer.

Aranda A, Martínez-Iglesias O, Ruiz-Llorente L, García-Carpizo V, Zambrano A. Aranda A, et al. Trends Endocrinol Metab. 2009 Sep;20(7):318-24. doi: 10.1016/j.tem.2009.03.011. Epub 2009 Aug 26. Trends Endocrinol Metab. 2009. PMID: 19716314 Review.

8

Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives.

Pekarek L, Fraile-Martinez O, Garcia-Montero C, Alvarez-Mon MA, Acero J, Ruiz-Llorente L, García-Honduvilla N, Albillos A, Buján J, Alvarez-Mon M, Guijarro LG, Ortega MA. Pekarek L, et al. Among authors: ruiz llorente l. Oncol Lett. 2021 Nov;22(5):809. doi: 10.3892/ol.2021.13070. Epub 2021 Sep 27. Oncol Lett. 2021. PMID: 34630716 Free PMC article. Review.

9

Generation of a Soluble Form of Human Endoglin Fused to Green Fluorescent Protein.

Ruiz-Llorente L, Vega MC, Fernández FJ, Langa C, Morrell NW, Upton PD, Bernabeu C. Ruiz-Llorente L, et al. Int J Mol Sci. 2021 Oct 19;22(20):11282. doi: 10.3390/ijms222011282. Int J Mol Sci. 2021. PMID: 34681942 Free PMC article.

10

microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta.

Ruiz-Llorente L, Ardila-González S, Fanjul LF, Martínez-Iglesias O, Aranda A. Ruiz-Llorente L, et al. Oncotarget. 2014 May 30;5(10):2918-33. doi: 10.18632/oncotarget.1577. Oncotarget. 2014. PMID: 24796297 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters